TY  - JOUR
A1  - Noone, Stephanie
A1  - Schubert, Ralf
A1  - Fichtlscherer, Stephan
A1  - Hilberg, Thomas
A1  - Alesci, Sonja
A1  - Miesbach, Wolfgang
T1  - Endothelial function in patients with von Willebrand disease
T2  - Clinical and applied thrombosis, hemostasis
N2  - In patients with von Willebrand disease (vWD) the interest in age-related comorbidities has grown, because the life expectancy of these patients has increased. The research question of this study was whether patients with vWD show a different endothelial function compared to the general population. A total of 37 patients with type 1 (n = 23), type 2 (n = 10) and type 3 (n = 4) vWD, 14 controls and 38 patients with coronary artery disease (CAD) were included in this study. Five markers of endothelial dysfunction (MOED) were determined. Moreover, the endothelial function was examined using the Itamar Endo-PAT. The reactive hyperemia index (RHI) was calculated from the results. The markers soluble intercellular adhesion molecule-1 (p = 0.171), P-Selectin (p = 0.512), interleukin-6 (p = 0.734) and monocyte chemoattractant protein-1 (p = 0.761) showed higher levels in patients with vWD, but were not significantly different compared to the control group. RHI was impaired in CAD-patients (1.855), whereas vWD patients had mean results of 1.870 and controls 2.112 (p = 0.367). In this study, the endothelial function measurements of patients with von Willebrand disease were not significantly different compared to healthy controls.
KW  - von Willebrand disease
KW  - endothelial function
KW  - coronary artery disease
KW  - comorbidity
Y1  - 2021
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/57127
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-571279
SN  - 1938-2723
SN  - 1076-0296
VL  - 27
SP  - 1
EP  - 8
PB  - Sage
CY  - Thousand Oaks, Calif.
ER  -